who made tirzepatide Makes Zepbound: Eli Lilly's Development and FDA Approval Compounded Tirzepatide Weight Management Program
Description
On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist.
With new agreements from President Donald Trump promising lower prices on popularweight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher.
Roswell, NM
Real stories reveal what to expect and when to seek help.
